Active Ingredient(s): Loxapine
FDA Approved: * February 25, 1975
Pharm Company: * WATSON LABS
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Loxitane Overview

Loxapine, sold under the brand names Loxitane and Adasuve (inhalation only) among others, is a typical antipsychotic medication used primarily in the treatment of schizophrenia. The drug is a member of the dibenzoxazepine class and structurally related to clozapine. Several researchers have argued that loxapine may behave as an atypical antipsychotic.[2] Loxapine may be metabolized by N-demethylation to amoxapine, a tricyclic antidepressant.[3] Contents 1 Med...

Read more Loxitane Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loxapine

Recent Loxitane Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 10mg, 25mg, 50mg, 50mg *federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons**, 5mg
  • Syrup: 25mg/ml
  • Tablet: 10mg, 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Loxitane: (4 results)

Sorted by National Drug Code
  • 52544-494 Loxitane 5 mg Oral Capsule by Watson Pharma, Inc.
  • 52544-495 Loxitane 10 mg Oral Capsule by Watson Pharma, Inc.
  • 52544-496 Loxitane 25 mg Oral Capsule by Watson Pharma, Inc.
  • 52544-497 Loxitane 50 mg Oral Capsule by Watson Pharma, Inc.

Other drugs which contain Loxapine or a similar ingredient: (1 result)